Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
life sciences
national blog main
20/20 healthcare partners
akcea therapeutics
alnylam pharmaceuticals
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
biotech
christian angermayer
dolby family ventures
drugs
enclear therapies
european medicines agency
fda
financing
funding
gf securities
global health sciences fund
harvard pilgrim health care
hereditary transthyretin amyloidosis
hillel bachrach
inotersen
institute for clinical and economic review
jason camm
karimah es sabar
labcentral
medical device
national top stories
new york blog main
new york top stories
onpattro
patisiran
peter thiel
pfizer
presight capital
quark venture
What
harmful
2
×
alnylam
approves
associated
cells
companies
develop
device
dialysis
disease
diseases
drug
drugs
ema
employ
enclear
europe
fda
follows
gene
hits
interference
make
medicine
method
mute
nets
neuro
neurodegenerative
new
protein
proteins
raised
rna
rnai
target
test
therapies
uses
way
Language
unset
Current search:
harmful
×
boston
×
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
